Patterns of finasteride and dutasteride use in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial cohort: effects of socio-demographic factors and a black box warning

Background: Five-alpha reductase inhibitors (5-ARIs), specifically finasteride and dutasteride, have been shown to significantly reduce prostate cancer incidence. However, these agents were also associated with a significant increase in the detection of high-grade prostate cancer leading to an FD...

Full description

Bibliographic Details
Main Authors: Jarrett A. Johnson, Paul F. Pinsky, Howard L. Parnes, Damali N. Martin
Format: Article
Language:English
Published: MRE Press 2022-01-01
Series:Journal of Men's Health
Subjects:
Online Access:https://article.imrpress.com/journal/JOMH/18/1/10.31083/j.jomh1801019/1875-6859-18-1-019.pdf